 | • レポートコード：GIR-107A14828 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、80ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ネプリライシンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ネプリライシンの種類別市場規模（TD-0714、STR-324、PL-265、LHW-090、その他）、用途別市場規模（急性心不全、がん性疼痛、高血圧、アルツハイマー病、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ネプリライシンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bioprojet SCR、Novartis AG、Pharmaleads SA、Theravance Biopharma Inc ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：TD-0714、STR-324、PL-265、LHW-090、その他 ・用途別分析2016年-2026年：急性心不全、がん性疼痛、高血圧、アルツハイマー病、その他 ・ネプリライシンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ネプリライシンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ネプリライシンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ネプリライシンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ネプリライシンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Neprilysin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Neprilysin size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Neprilysin market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Neprilysin market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
TD-0714
STR-324
PL-265
LHW-090
Others
Market segment by Application can be divided into
Acute Heart Failure
Cancer Pain
Hypertension
Alzheimer’s Disease
Others
The key market players for global Neprilysin market are listed below:
Bioprojet SCR
Novartis AG
Pharmaleads SA
Theravance Biopharma Inc
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Neprilysin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Neprilysin, with price, sales, revenue and global market share of Neprilysin from 2019 to 2021.
Chapter 3, the Neprilysin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neprilysin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Neprilysin market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Neprilysin sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Neprilysin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Neprilysin Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 TD-0714
1.2.3 STR-324
1.2.4 PL-265
1.2.5 LHW-090
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Neprilysin Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Acute Heart Failure
1.3.3 Cancer Pain
1.3.4 Hypertension
1.3.5 Alzheimer’s Disease
1.3.6 Others
1.4 Global Neprilysin Market Size & Forecast
1.4.1 Global Neprilysin Sales in Value (2016-2026))
1.4.2 Global Neprilysin Sales in Volume (2016-2026)
1.4.3 Global Neprilysin Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Neprilysin Production Capacity Analysis
1.5.1 Global Neprilysin Total Production Capacity (2016-2026)
1.5.2 Global Neprilysin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Neprilysin Market Drivers
1.6.2 Neprilysin Market Restraints
1.6.3 Neprilysin Trends Analysis
2 Manufacturers Profiles
2.1 Bioprojet SCR
2.1.1 Bioprojet SCR Details
2.1.2 Bioprojet SCR Major Business
2.1.3 Bioprojet SCR Neprilysin Product and Services
2.1.4 Bioprojet SCR Neprilysin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Novartis AG
2.2.1 Novartis AG Details
2.2.2 Novartis AG Major Business
2.2.3 Novartis AG Neprilysin Product and Services
2.2.4 Novartis AG Neprilysin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Pharmaleads SA
2.3.1 Pharmaleads SA Details
2.3.2 Pharmaleads SA Major Business
2.3.3 Pharmaleads SA Neprilysin Product and Services
2.3.4 Pharmaleads SA Neprilysin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Theravance Biopharma Inc
2.4.1 Theravance Biopharma Inc Details
2.4.2 Theravance Biopharma Inc Major Business
2.4.3 Theravance Biopharma Inc Neprilysin Product and Services
2.4.4 Theravance Biopharma Inc Neprilysin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Neprilysin Sales by Manufacturer
3.1 Global Neprilysin Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Neprilysin Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Neprilysin
3.4 Market Concentration Rate
3.4.1 Top 3 Neprilysin Manufacturer Market Share
3.4.2 Top 6 Neprilysin Manufacturer Market Share
3.5 Global Neprilysin Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Neprilysin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Neprilysin Market Size by Region
4.1.1 Global Neprilysin Sales in Volume by Region (2016-2026)
4.1.2 Global Neprilysin Revenue by Region (2016-2026)
4.2 North America Neprilysin Revenue (2016-2026)
4.3 Europe Neprilysin Revenue (2016-2026)
4.4 Asia-Pacific Neprilysin Revenue (2016-2026)
4.5 South America Neprilysin Revenue (2016-2026)
4.6 Middle East and Africa Neprilysin Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Neprilysin Sales in Volume by Type (2016-2026)
5.2 Global Neprilysin Revenue by Type (2016-2026)
5.3 Global Neprilysin Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Neprilysin Sales in Volume by Application (2016-2026)
6.2 Global Neprilysin Revenue by Application (2016-2026)
6.3 Global Neprilysin Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Neprilysin Sales by Type (2016-2026)
7.2 North America Neprilysin Sales by Application (2016-2026)
7.3 North America Neprilysin Market Size by Country
7.3.1 North America Neprilysin Sales in Volume by Country (2016-2026)
7.3.2 North America Neprilysin Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Neprilysin Sales by Type (2016-2026)
8.2 Europe Neprilysin Sales by Application (2016-2026)
8.3 Europe Neprilysin Market Size by Country
8.3.1 Europe Neprilysin Sales in Volume by Country (2016-2026)
8.3.2 Europe Neprilysin Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Neprilysin Sales by Type (2016-2026)
9.2 Asia-Pacific Neprilysin Sales by Application (2016-2026)
9.3 Asia-Pacific Neprilysin Market Size by Region
9.3.1 Asia-Pacific Neprilysin Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Neprilysin Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Neprilysin Sales by Type (2016-2026)
10.2 South America Neprilysin Sales by Application (2016-2026)
10.3 South America Neprilysin Market Size by Country
10.3.1 South America Neprilysin Sales in Volume by Country (2016-2026)
10.3.2 South America Neprilysin Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Neprilysin Sales by Type (2016-2026)
11.2 Middle East & Africa Neprilysin Sales by Application (2016-2026)
11.3 Middle East & Africa Neprilysin Market Size by Country
11.3.1 Middle East & Africa Neprilysin Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Neprilysin Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Neprilysin Typical Distributors
12.3 Neprilysin Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Neprilysin Revenue by Type, (USD Million), 2021-2026
Table 2. Global Neprilysin Revenue by Application, (USD Million), 2021-2026
Table 3. Bioprojet SCR Basic Information, Manufacturing Base and Competitors
Table 4. Bioprojet SCR Major Business
Table 5. Bioprojet SCR Neprilysin Product and Services
Table 6. Bioprojet SCR Neprilysin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 8. Novartis AG Major Business
Table 9. Novartis AG Neprilysin Product and Services
Table 10. Novartis AG Neprilysin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Pharmaleads SA Basic Information, Manufacturing Base and Competitors
Table 12. Pharmaleads SA Major Business
Table 13. Pharmaleads SA Neprilysin Product and Services
Table 14. Pharmaleads SA Neprilysin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Theravance Biopharma Inc Basic Information, Manufacturing Base and Competitors
Table 16. Theravance Biopharma Inc Major Business
Table 17. Theravance Biopharma Inc Neprilysin Product and Services
Table 18. Theravance Biopharma Inc Neprilysin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Global Neprilysin Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 20. Global Neprilysin Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 21. Market Position of Manufacturers in Neprilysin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 22. Global Neprilysin Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 23. Head Office and Neprilysin Production Site of Key Manufacturer
Table 24. Neprilysin New Entrant and Capacity Expansion Plans
Table 25. Neprilysin Mergers & Acquisitions in the Past Five Years
Table 26. Global Neprilysin Sales by Region (2016-2021e) & (K Pcs)
Table 27. Global Neprilysin Sales by Region (2021-2026) & (K Pcs)
Table 28. Global Neprilysin Revenue by Region (2016-2021e) & (USD Million)
Table 29. Global Neprilysin Revenue by Region (2021-2026) & (USD Million)
Table 30. Global Neprilysin Sales by Type (2016-2021e) & (K Pcs)
Table 31. Global Neprilysin Sales by Type (2021-2026) & (K Pcs)
Table 32. Global Neprilysin Revenue by Type (2016-2021e) & (USD Million)
Table 33. Global Neprilysin Revenue by Type (2021-2026) & (USD Million)
Table 34. Global Neprilysin Price by Type (2016-2021e) & (USD/Pcs)
Table 35. Global Neprilysin Price by Type (2021-2026) & (USD/Pcs)
Table 36. Global Neprilysin Sales by Application (2016-2021e) & (K Pcs)
Table 37. Global Neprilysin Sales by Application (2021-2026) & (K Pcs)
Table 38. Global Neprilysin Revenue by Application (2016-2021e) & (USD Million)
Table 39. Global Neprilysin Revenue by Application (2021-2026) & (USD Million)
Table 40. Global Neprilysin Price by Application (2016-2021e) & (USD/Pcs)
Table 41. Global Neprilysin Price by Application (2021-2026) & (USD/Pcs)
Table 42. North America Neprilysin Sales by Country (2016-2021e) & (K Pcs)
Table 43. North America Neprilysin Sales by Country (2021-2026) & (K Pcs)
Table 44. North America Neprilysin Revenue by Country (2016-2021e) & (USD Million)
Table 45. North America Neprilysin Revenue by Country (2021-2026) & (USD Million)
Table 46. North America Neprilysin Sales by Type (2016-2021e) & (K Pcs)
Table 47. North America Neprilysin Sales by Type (2021-2026) & (K Pcs)
Table 48. North America Neprilysin Sales by Application (2016-2021e) & (K Pcs)
Table 49. North America Neprilysin Sales by Application (2021-2026) & (K Pcs)
Table 50. Europe Neprilysin Sales by Country (2016-2021e) & (K Pcs)
Table 51. Europe Neprilysin Sales by Country (2021-2026) & (K Pcs)
Table 52. Europe Neprilysin Revenue by Country (2016-2021e) & (USD Million)
Table 53. Europe Neprilysin Revenue by Country (2021-2026) & (USD Million)
Table 54. Europe Neprilysin Sales by Type (2016-2021e) & (K Pcs)
Table 55. Europe Neprilysin Sales by Type (2021-2026) & (K Pcs)
Table 56. Europe Neprilysin Sales by Application (2016-2021e) & (K Pcs)
Table 57. Europe Neprilysin Sales by Application (2021-2026) & (K Pcs)
Table 58. Asia-Pacific Neprilysin Sales by Region (2016-2021e) & (K Pcs)
Table 59. Asia-Pacific Neprilysin Sales by Region (2021-2026) & (K Pcs)
Table 60. Asia-Pacific Neprilysin Revenue by Region (2016-2021e) & (USD Million)
Table 61. Asia-Pacific Neprilysin Revenue by Region (2021-2026) & (USD Million)
Table 62. Asia-Pacific Neprilysin Sales by Type (2016-2021e) & (K Pcs)
Table 63. Asia-Pacific Neprilysin Sales by Type (2021-2026) & (K Pcs)
Table 64. Asia-Pacific Neprilysin Sales by Application (2016-2021e) & (K Pcs)
Table 65. Asia-Pacific Neprilysin Sales by Application (2021-2026) & (K Pcs)
Table 66. South America Neprilysin Sales by Country (2016-2021e) & (K Pcs)
Table 67. South America Neprilysin Sales by Country (2021-2026) & (K Pcs)
Table 68. South America Neprilysin Revenue by Country (2016-2021e) & (USD Million)
Table 69. South America Neprilysin Revenue by Country (2021-2026) & (USD Million)
Table 70. South America Neprilysin Sales by Type (2016-2021e) & (K Pcs)
Table 71. South America Neprilysin Sales by Type (2021-2026) & (K Pcs)
Table 72. South America Neprilysin Sales by Application (2016-2021e) & (K Pcs)
Table 73. South America Neprilysin Sales by Application (2021-2026) & (K Pcs)
Table 74. Middle East & Africa Neprilysin Sales by Country (2016-2021e) & (K Pcs)
Table 75. Middle East & Africa Neprilysin Sales by Country (2021-2026) & (K Pcs)
Table 76. Middle East & Africa Neprilysin Revenue by Country (2016-2021e) & (USD Million)
Table 77. Middle East & Africa Neprilysin Revenue by Country (2021-2026) & (USD Million)
Table 78. Middle East & Africa Neprilysin Sales by Type (2016-2021e) & (K Pcs)
Table 79. Middle East & Africa Neprilysin Sales by Type (2021-2026) & (K Pcs)
Table 80. Middle East & Africa Neprilysin Sales by Application (2016-2021e) & (K Pcs)
Table 81. Middle East & Africa Neprilysin Sales by Application (2021-2026) & (K Pcs)
Table 82. Direct Channel Pros & Cons
Table 83. Indirect Channel Pros & Cons
Table 84. Neprilysin Typical Distributors
Table 85. Neprilysin Typical Customers
List of Figures
Figure 1. Neprilysin Picture
Figure 2. Global Neprilysin Sales Market Share by Type in 2020
Figure 3. TD-0714
Figure 4. STR-324
Figure 5. PL-265
Figure 6. LHW-090
Figure 7. Others
Figure 8. Global Neprilysin Sales Market Share by Application in 2020
Figure 9. Acute Heart Failure
Figure 10. Cancer Pain
Figure 11. Hypertension
Figure 12. Alzheimer's Disease
Figure 13. Others
Figure 14. Global Neprilysin Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 15. Global Neprilysin Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. Global Neprilysin Sales (2016-2026) & (K Pcs)
Figure 17. Global Neprilysin Price by Type (2016-2026) & (USD/Pcs)
Figure 18. Global Neprilysin Production Capacity (2016-2026) & (K Pcs)
Figure 19. Global Neprilysin Production Capacity by Geographic Region: 2020 VS 2021
Figure 20. Neprilysin Market Drivers
Figure 21. Neprilysin Market Restraints
Figure 22. Neprilysin Market Trends
Figure 23. Global Neprilysin Sales Market Share by Manufacturer in 2020
Figure 24. Global Neprilysin Revenue Market Share by Manufacturer in 2020
Figure 25. Neprilysin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. Top 3 Neprilysin Manufacturer (Revenue) Market Share in 2020
Figure 27. Top 6 Neprilysin Manufacturer (Revenue) Market Share in 2020
Figure 28. Global Neprilysin Sales Market Share by Region (2016-2026)
Figure 29. Global Neprilysin Revenue Market Share by Region (2016-2026)
Figure 30. North America Neprilysin Revenue (2016-2026) & (USD Million)
Figure 31. Europe Neprilysin Revenue (2016-2026) & (USD Million)
Figure 32. Asia-Pacific Neprilysin Revenue (2016-2026) & (USD Million)
Figure 33. South America Neprilysin Revenue (2016-2026) & (USD Million)
Figure 34. Middle East & Africa Neprilysin Revenue (2016-2026) & (USD Million)
Figure 35. Global Neprilysin Sales Market Share by Type (2016-2026)
Figure 36. Global Neprilysin Revenue Market Share by Type (2016-2026)
Figure 37. Global Neprilysin Price by Type (2016-2026) & (USD/Pcs)
Figure 38. Global Neprilysin Sales Market Share by Application (2016-2026)
Figure 39. Global Neprilysin Revenue Market Share by Application (2016-2026)
Figure 40. Global Neprilysin Price by Application (2016-2026) & (USD/Pcs)
Figure 41. North America Neprilysin Sales Market Share by Type (2016-2026)
Figure 42. North America Neprilysin Sales Market Share by Application (2016-2026)
Figure 43. North America Neprilysin Sales Market Share by Country (2016-2026)
Figure 44. North America Neprilysin Revenue Market Share by Country (2016-2026)
Figure 45. United States Neprilysin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Neprilysin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Neprilysin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Neprilysin Sales Market Share by Type (2016-2026)
Figure 49. Europe Neprilysin Sales Market Share by Application (2016-2026)
Figure 50. Europe Neprilysin Sales Market Share by Country (2016-2026)
Figure 51. Europe Neprilysin Revenue Market Share by Country (2016-2026)
Figure 52. Germany Neprilysin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Neprilysin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Neprilysin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Neprilysin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Neprilysin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Neprilysin Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Neprilysin Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Neprilysin Sales Market Share by Region (2016-2026)
Figure 60. Asia-Pacific Neprilysin Revenue Market Share by Region (2016-2026)
Figure 61. China Neprilysin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Neprilysin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Korea Neprilysin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Neprilysin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Neprilysin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Neprilysin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Neprilysin Sales Market Share by Type (2016-2026)
Figure 68. South America Neprilysin Sales Market Share by Application (2016-2026)
Figure 69. South America Neprilysin Sales Market Share by Country (2016-2026)
Figure 70. South America Neprilysin Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Neprilysin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Neprilysin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East & Africa Neprilysin Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Neprilysin Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Neprilysin Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Neprilysin Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Neprilysin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Egypt Neprilysin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Neprilysin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. South Africa Neprilysin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
世界の心不全検査市場 2021：企業別、地域別、種類・用途別 The Heart Failure Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…- 世界のアルツハイマー病市場 2021：企業別、地域別、種類・用途別 The Alzheimer's Disease market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 世界の先天性心疾患治療市場 2021：企業別、地域別、種類・用途別 The Congenital Heart Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 世界の人工心肺装置市場 2021：企業別、地域別、種類・用途別 The Heart Lung Machine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…
- 心不全治療薬市場：世界及び中国市場分析・予測（～2024年） Heart Failure Drugs Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Heart Failure Drugs industry with a focus on the Chinese market. The report provides key statistics on the market status of the Heart Failure Drugs manufactur…